Cargando…

Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia

Background: People diagnosed with schizophrenia have a much reduced life expectancy compared to the general population, and a more than doubled risk of dying from cardiovascular disease (CVD). Existing CVD risk calculators can be used to detect people with an elevated predicted risk of CVD to inform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berry, Alexandra, Drake, Richard J., Webb, Roger T., Ashcroft, Darren M., Carr, Matthew J., Yung, Alison R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315171/ https://www.ncbi.nlm.nih.gov/pubmed/30631286 http://dx.doi.org/10.3389/fpsyt.2018.00685

Ejemplares similares

Prevalence of Major Cardiovascular Disease Events Among People Diagnosed With Schizophrenia Who Have Sleep Disturbance, Sedentary Behavior, or Muscular Weakness
por: Berry, Alexandra, et al.
Publicado: (2021)

S163. FEASIBILITY STUDY: MEASURES OF SLEEP AND PHYSICAL ACTIVITY IN PEOPLE WITH SCHIZOPHRENIA
por: Berry, Alexandra, et al.
Publicado: (2018)

Examining healthcare professionals’ beliefs and actions regarding the physical health of people with schizophrenia
por: Berry, Alexandra, et al.
Publicado: (2020)

The recovery of homicidal people diagnosed with schizophrenia and schizoaffective disorder—An interpretative phenomenological analysis
por: Kovács, Asztrik, et al.
Publicado: (2023)

Expressed Emotion and Attributions in Parents With Schizophrenia
por: Gregg, Lynsey, et al.
Publicado: (2021)

An Evaluation of an Online Training Platform for Teaching Positive Emotions for People With Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2022)

Effects of a virtual reality serious game training program on the cognitive function of people diagnosed with schizophrenia: A randomized controlled trial
por: Wang, Xu, et al.
Publicado: (2022)

COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis
por: Mohan, Mohapradeep, et al.
Publicado: (2021)

Risk factors for self-harm in people with epilepsy
por: Gorton, Hayley C., et al.
Publicado: (2018)

Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia
por: Laraki, Yasmine, et al.
Publicado: (2023)

Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes
por: Carr, Matthew J., et al.
Publicado: (2020)

Psychiatric Diagnoses and Treatment Preceding Schizophrenia in Adolescents Aged 9–17 Years
por: Kang-Yi, Christina D., et al.
Publicado: (2020)

Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing Research
por: Baker, Amanda L., et al.
Publicado: (2018)

Editorial: Case reports in schizophrenia and psychotic disorders
por: Tusconi, Massimo, et al.
Publicado: (2023)

Cardiovascular Diseases and Schizophrenia in India: Evidence, Gaps, and Way Forward
por: Padmavati, Ramachandran, et al.
Publicado: (2021)

Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
por: Carr, Matthew J, et al.
Publicado: (2021)

Vocational Profile and Correlates of Employment in People With Schizophrenia: The Role of Avolition
por: Ang, Mei San, et al.
Publicado: (2020)

Referential communication in people with recent-onset schizophrenia-spectrum disorders
por: Achim, Amélie M., et al.
Publicado: (2022)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
por: Vasiliu, Octavian
Publicado: (2021)

Dog-assisted interventions for adults diagnosed with schizophrenia and related disorders: a systematic review
por: Tyssedal, Malene Kalsnes, et al.
Publicado: (2023)

Absence of Excess Intra-Individual Variability in Retinal Function in People With Schizophrenia
por: Fradkin, Samantha I., et al.
Publicado: (2020)

Personal Recovery and Its Determinants Among People Living With Schizophrenia in China
por: Yu, Yu, et al.
Publicado: (2020)

Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review
por: Johnstone, Samantha, et al.
Publicado: (2022)

Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial
por: Tessier, Arnaud, et al.
Publicado: (2023)

Social Cognition Analyzer Application—A New Method for the Analysis of Social Cognition in Patients Diagnosed With Schizophrenia
por: Varga, Eszter, et al.
Publicado: (2019)

Characteristics of People Returned to Prison From Medium Secure Psychiatric Services in England and Wales: National Cohort Study
por: Leonard, Sarah, et al.
Publicado: (2022)

Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia
por: Nguyen, Alexandra, et al.
Publicado: (2016)

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial
por: Marx, Wolfgang, et al.
Publicado: (2021)

Improving Social Cognition in People with Schizophrenia with RC2S: Two Single-Case Studies
por: Peyroux, Elodie, et al.
Publicado: (2016)

A Systematic Review of Psychosocial Barriers and Facilitators to Smoking Cessation in People Living With Schizophrenia
por: Lum, Alistair, et al.
Publicado: (2018)

Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review
por: Tumiel, Ewa, et al.
Publicado: (2019)

Heterogeneity of resilience and the curvilinear relationship between childhood trauma and resilience among people with schizophrenia
por: Wang, Weiliang, et al.
Publicado: (2023)

Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
por: Gao, Shuzhan, et al.
Publicado: (2020)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
por: Tang, Yiguo, et al.
Publicado: (2021)

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting
por: Potvin, Stéphane, et al.
Publicado: (2020)

Cortical Gray Matter Loss, Augmented Vulnerability to Speech-on-Speech Masking, and Delusion in People With Schizophrenia
por: Wu, Chao, et al.
Publicado: (2018)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
por: Kinon, Bruce J.
Publicado: (2019)

The Gut Microbiome and Schizophrenia: The Current State of the Field and Clinical Applications
por: Szeligowski, Tomasz, et al.
Publicado: (2020)

Homicide by men diagnosed with schizophrenia: national case–control study
por: Baird, Alison, et al.
Publicado: (2020)

Differentiating people with schizophrenia from healthy controls in a developing Country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool
por: Tran, Bach Xuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cud64s3evad9ncpn3jabgqeno6